The Lung Ambition Alliance approached Ipsos MORI to survey healthcare professionals (HCPs) and the adult populations of EU5 (UK, Germany, France Spain and Italy), the US, and Japan in order to gauge current attitudes to and awareness of lung cancer. The research is designed to generate insight that can drive a campaign focusing on greater public understanding of lung cancer and those affected by it.
On behalf of AstraZeneca and the Lung Ambition Alliance, Ipsos MORI interviewed 7,000 adults aged 18 and over across 7 countries (UK, Germany, France, Spain, Italy, US and Japan). Interviews were conducted online between 22nd October and 4th November 2019. Respondents from an online panel have been selected using statistical sampling following adjustments to criteria on gender, age, socio-professional category, geographical area and type of city based on census data available in each country for the population aged 18 and over. Results for each country have been weighted (Rim Weighting method) to reflect the population size of people aged 18 years and above to ensure sample is nationally representative within each market. Results have been also weighted to ensure that each country have the same weight when aggregated.